Neonatal Diseases
Conditions
Interventions
Fiberoptic phototherapy
Blue light conventional phototherapy
White light phototherapy
Sponsors
Helvi N Joel
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: All term neonates (>37 weeks of gestation), less than 7 days of age, with unconjugated hyperbilirubinemia with a total bilirubin level that has reached phototherapy threshold values as per the American Academy of Pediatrics (AAP) nomogram values.
Exclusion criteria
Exclusion criteria: • Newborns receiving phenobarbitone. • Newborns with bilirubin levels that have reached exchange transfusion levels on the AAP nomogram. • Newborns with conjugated hyperbilirubinaemia. • Newborns who have already received phototherapy prior to enrollment. • Newborns whose parents refused to consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin reduction;Treatment Duration;Treatment Side effects: decreased intestinal transit time: loose, greenish stools; hydration status: slow weight gain, assessed as the difference in daily body weight after starting PT, a difference of more than 5% body weight loss was considered as dehydrated; skin rashes and brownish discoloration of skin were assessed by a dermatologist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Age at enrollment;Gestation age at birth;Total serum bilirubin;Direct serum bilirubin | — |
Countries
United Republic of Tanzania
Contacts
Public ContactRonald Mbwasi
Kilimanjaro Christian Medical Centre
Outcome results
None listed